Medilexicon International Industry Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
as on 09-01-2025
- Paid Up Capital ₹ 2.60 M
as on 09-01-2025
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.05 M
as on 09-01-2025
- Revenue 312.69%
(FY 2020)
- Profit 278.90%
(FY 2020)
- Ebitda 3245.13%
(FY 2020)
- Net Worth 10.35%
(FY 2020)
- Total Assets 284.51%
(FY 2020)
About Medilexicon International Industry
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹3.05 M.
Rohan Singhal and Kiran Sharma serve as directors at the Company.
- CIN/LLPIN
U74999RJ2019PTC063691
- Company No.
063691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medilexicon International Industry?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Singhal  | Director | 23-Feb-2023 | Current |
| Kiran Sharma | Director | 17-Jan-2019 | Current |
Financial Performance of Medilexicon International Industry.
Medilexicon International Industry Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 312.69% increase. The company also saw a substantial improvement in profitability, with a 278.9% increase in profit. The company's net worth Soared by an impressive increase of 10.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilexicon International Industry?
In 2020, Medilexicon International Industry had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Medilexicon Pharmaceuticals Private LimitedActive 15 years 7 months
Rohan Singhal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jul 2020 | ₹2.10 M | Open |
Others Creation Date: 27 Jun 2019 | ₹0.95 M | Open |
How Many Employees Work at Medilexicon International Industry?
Unlock and access historical data on people associated with Medilexicon International Industry, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilexicon International Industry, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilexicon International Industry's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
